SCH 66336

lonafarnib · Schering-Plough

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SCH 66336, covering 2009-10-14 to 2012-09-24. Get the full timeline:

Most recent: Clinical Trial Update: SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract [Phase 2]